Also trades as: 0IGA.L (LSE) · $vol 0M
EBS NYSE
Emergent BioSolutions Inc.
1W: +1.9%
1M: +1.0%
3M: -23.4%
YTD: -33.1%
1Y: +20.6%
3Y: -5.6%
5Y: -86.5%
$8.45
+0.08 (+0.96%)
Weekly Expected Move ±7.6%
$7
$7
$8
$9
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$677M
Revenue
-29.9% YoY
$-9M
Net Income
+93.5% YoY
$135M
Free Cash Flow
+43.4% YoY
43.3%
Gross Margin
6.7%
Op. Margin
4.4%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-1.7%
ROA-0.6%
ROIC-19.9%
Valuation
P/E-51.0
P/B0.8
EV/EBITDA5.2
Leverage
Debt/Equity1.09
Current Ratio5.01
Interest Cov.1.2x
Quality Scores
Piotroski F5/9
Altman Z1.35
Beneish M-3.48